The skin is the largest organ of the body, whose main function is to protect the body against the loss of physiologically important components as well as harmful environmental insults. From the inside to the outside, the skin comprises three major structural layers: the hypodermis, the dermis and the epidermis. The epidermis contains four different sublayers, the stratum corneum (SC), stratum granulosum, stratum spinosum and stratum basale, where the barrier function of the skin mainly lies in the outermost layer of the epidermis, the SC. The SC contains corneocytes that are embedded in a lipid matrix existing in the form of lipid bilayers. The lipid bilayers are formed mainly from ceramides, free fatty acids and cholesterol, constitute the only continuous pathway across the SC and are responsible for the barrier function of the skin. However, the depletion or disturbance of SC lipids in the SC leads to a perturbation of the barrier function of the skin, and, conversely, several skin diseases such as psoriasis and atopic dermatitis are associated with the depletion of these SC lipids. Therefore, it is of paramount importance to understand the interrelationship between the depletion of SC lipids and skin diseases as well as factors that affect the composition and organization of SC lipids in order to assess the potential benefit of a direct replacement of the missing SC lipids as a means of treating affected, aged or diseased skin. i 2014 S. Karger AG, Basel

Keywords:
Ceramides, Cholesterol, Free fatty acids, Lipid replenishment therapy, Skin diseases, Stratum corneum
1.
El Maghraby GM, Barry BW, Williams AC: Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-222.
2.
Holleran WM, Takagi Y, Uchida Y: Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 2006;580:5456-5466.
3.
Shah UU, Roberts M, Gul MO, Tuleu C, Beresford MW; NIHR MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group: Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm 2011;416:1-11.
4.
Bouwstra JA, Ponec M: The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006;1758:2080-2095.
5.
Bonte F, Pinguet P, Chevalier JM, Meybeck A: Analysis of all stratum corneum lipids by automated multiple development high-performance thin-layer chromatography. J Chromatogr B Biomed Appl 1995;664:311-316.
6.
Bonte F, Pinguet P, Saunois A, Meybeck A, Beugin S, Ollivon M, Lesieur S: Thermotropic phase behavior of in vivo extracted human stratum corneum lipids. Lipids 1997;32:653-660.
7.
Ponec M, Weerheim A, Lankhorst P, Wertz P: New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003;120:581-588.
8.
de Jager MW, Gooris GS, Dolbnya IP, Bras W, Ponec M, Bouwstra JA: The phase behaviour of skin lipid mixtures based on synthetic ceramides. Chem Phys Lipids 2003;124:123-134.
9.
Hatfield RM, Fung LW: Molecular properties of a stratum corneum model lipid system: large unilamellar vesicles. Biophys J 1995;68:196-207.
10.
Groen D, Gooris GS, Ponec M, Bouwstra JA: Two new methods for preparing a unique stratum corneum substitute. Biochim Biophys Acta 2008;1778:2421-2429.
11.
Ishikawa J, Shimotoyodome Y, Chen S, Ohkubo K, Takagi Y, Fujimura T, Kitahara T, Takema Y: Eucalyptus increases ceramide levels in keratinocytes and improves stratum corneum function. Int J Cosmet Sci 2012;34:17-22.
12.
Zhang L, Hellgren LI, Xu X: Enzymatic production of ceramide from sphingomyelin. J Biotechnol 2006;123:93-105.
13.
Farwanah H, Raith K, Neubert RH, Wohlrab J: Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin. Arch Dermatol Res 2005;296:514-521.
14.
Lampe MA, Williams ML, Elias PM: Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res 1983;24:131-140.
15.
Proksch E, Jensen JM, Elias PM: Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 2003;21:134-144.
16.
Weerheim A, Ponec M: Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res 2001;293:191-199.
17.
Loden M: The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol 2003;21:145-157.
18.
Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y: Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 2009;91:784-790.
19.
de Jager MW, Gooris GS, Dolbnya IP, Ponec M, Bouwstra JA: Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic ceramide composition. Biochim Biophys Acta 2004;1664:132-140.
20.
Kang L, Ho PC, Chan SY: Interactions between a skin penetration enhancer and the main components of human stratum corneum lipids isothermal titration calorimetry study. J Therm Anal Calorim 2006;83:27-30.
21.
Hatta I, Ohta N, Inoue K, Yagi N: Coexistence of two domains in intercellular lipid matrix of stratum corneum. Biochim Biophys Acta 2006;1758:1830-1836.
22.
de Jager MW, Gooris GS, Dolbnya IP, Bras W, Ponec M, Bouwstra JA: Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization. J Lipid Res 2004;45:923-932.
23.
Norl3n L, Gil IP, Simonsen A, Descouts P: Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films. J Struct Biol 2007;158:386-400.
24.
Bonte F, Saunois A, Pinguet P, Meybeck A: Existence of a lipid gradient in the upper stratum corneum and its possible biological significance. Arch Dermatol Res 1997;289:78-82.
25.
Joo KM, Nam GW, Park SY, Han JY, Jeong HJ, Lee SY, Kim HK, Lim KM: Relationship between cutaneous barrier function and ceramide species in human stratum corneum. J Dermatol Sci 2010;60:47-50.
26.
Jungersted JM, Hogh JK, Hellgren LI, Jemec GBE, Agner T: Ethnicity and stratum corneum ceramides. Br J Dermatol 2010;163:1169-1173.
27.
Norl3n L, Nicander I, Lundh Rozell B, Ollmar S, Forslind B: Inter- and intra-individual differences in human stratum corneum lipid content related to physical parameters of skin barrier function in vivo. J Invest Dermatol 1999;112:72-77.
28.
Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T, Takema Y, Kita K: Characterization of overall ceramide species in human stratum corneum. J Lipid Res 2008;49:1466-1476.
29.
van Smeden J, Hoppel L, van der Heijden R, Hankemeier T, Vreeken RJ, Bouwstra JA: LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery. J Lipid Res 2011;52:1211-1221.
30.
t'Kindt R, Jorge L, Dumont E, Couturon P, David F, Sandra P, Sandra K: Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal Chem 2012;84:403-411.
31.
Farwanah H, Wohlrab J, Neubert RH, Raith K: Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS. Anal Bioanal Chem 2005;383:632-637.
32.
Ramesh G, Das UN: Effect of free fatty acids on two-stage skin carcinogenesis in mice. Cancer Lett 1996;100:199-209.
33.
Ziboh VA, Miller CC, Cho Y: Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr 2000;71:361S-366S.
34.
Hinder A, Schmelzer CEH, Rawlings AV, Neubert RHH: Investigation of the molecular structure of the human stratum corneum ceramides [NP] and [EOS] by mass spectrometry. Skin Pharmacol Physiol 2011;24:127-135.
35.
Ansari MNA, Nicolaides N, Fu HC: Fatty acid composition of the living layer and stratum corneum lipids of human sole skin epidermis. Lipids 1970;5:838-845.
36.
Terashi H, Izumi K, Rhodes LM, Marcelo CL: Human stratified squamous epithelia differ in cellular fatty acid composition. J Dermatol Sci 2000;24:14-24.
37.
Jiang WG, Bryce RP, Horrobin DF: Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998;27:179-209.
38.
Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G: Deficient production of hexadecanoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology 2005;211:240-248.
39.
Chen X, Kwak S, Lafleur M, Bloom M, Kitson N, Thewalt J: Fatty acids influence ‘solid' phase formation in models of stratum corneum intercellular membranes. Langmuir 2007;23:5548-5556.
40.
Brody I: A light and electron microscopy study of normal human stratum corneum with particular reference to the intercellular space. Ups J Med Sci 1989;94:29-45.
41.
Bouwstra JA, Dubbelaar FE, Gooris GS, Ponec M: The lipid organisation in the skin barrier. Acta Derm Venereol Suppl (Stockh) 2000;208:23-30.
42.
Forslind B: A domain mosaic model of the skin barrier. Acta Derm Venereol 1994;74:1-6.
43.
Kiselev MA, Ryabova NY, Balagurov AM, Dante S, Hauss T, Zbytovska J, Wartewig S, Neubert RH: New insights into the structure and hydration of a stratum corneum lipid model membrane by neutron diffraction. Eur Biophys J 2005;34:1030-1040.
44.
ten Grotenhuis E, Demel RA, Ponec M, Boer DR, van Miltenburg JC, Bouwstra JA: Phase behavior of stratum corneum lipids in mixed Langmuir-Blodgett monolayers. Biophys J 1996;71:1389-1399.
45.
SchrFter A, Kessner D, Kiselev MA, Hauss T, Dante S, Neubert RH: Basic nanostructure of stratum corneum lipid matrices based on ceramides [EOS] and [AP]: a neutron diffraction study. Biophys J 2009;97:1104-1114.
46.
Norl3n L: Skin barrier structure and function: the single gel phase model. J Invest Dermatol 2001;117:830-836.
47.
Kiselev MA: Conformation of ceramide 6 molecules and chain-flip transitions in the lipid matrix of the outermost layer of mammalian skin, the stratum corneum. Crystallogr Rep 2007;52:525-528.
48.
Kessner D, Ruettinger A, Kiselev MA, Wartewig S, Neubert RH: Properties of ceramides and their impact on the stratum corneum structure. Part 2. Stratum corneum lipid model systems. Skin Pharmacol Physiol 2008;21:58-74.
49.
Norl3n L: Molecular structure of the SC lipids in vivo. Skin Forum 12th Ann Meet, Frankfurt, 2011.
50.
Boncheva M, Damien F, Normand V: Molecular organization of the lipid matrix in intact stratum corneum using ATR-FTIR spectroscopy. Biochim Biophys Acta 2008;1778:1344-1355.
51.
Caussin J, Gooris GS, Bouwstra JA: FTIR studies show lipophilic moisturizers to interact with stratum corneum lipids, rendering the more densely packed. Biochim Biophys Acta 2008;1778:1517-1524.
52.
Bouwstra JA, Honeywell-Nguyen PL: Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 2002;54(suppl 1):S41-S55.
53.
Caussin J, Gooris GS, Janssens M, Bouwstra JA: Lipid organization in human and porcine stratum corneum differs widely, while lipid mixtures with porcine ceramides model human stratum corneum lipid organization very closely. Biochim Biophys Acta 2008;1778:1472-1482.
54.
Corbe E, Laugel C, Yagoubi N, Baillet A: Role of ceramide structure and its microenvironment on the conformational order of model stratum corneum lipids mixtures: an approach by FTIR spectroscopy. Chem Phys Lipids 2007;146:67-75.
55.
Hong KK, Cho HR, Ju WC, Cho Y, Kim NI: A study on altered expression of serine palmitoyltransferase and ceramidase in psoriatic skin lesion. J Korean Med Sci 2007;22:862-867.
56.
Popa I, Bennaceur K, Abdul-Malak N, Perrier E, Schmitt D, Portoukalian J: Studies of compounds that enhance sphingolipid metabolism in human keratinocytes. Int J Cosmet Sci 2006;28:53-59.
57.
Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, Suzuki A, Elias PM, Holleran WM, Hamanaka S: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000;41:2071-2082.
58.
Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E: Consequences of F-glucocerebrosidase deficiency in epidermis: ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994;93:1756-1764.
59.
Alessandrini F, Stachowitz S, Ring J, Behrendt H: The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris. J Invest Dermatol 2001;116:394-400.
60.
Imokawa G: A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J Dermatol Sci 2009;55:1-9.
61.
Holleran WM, Gao WN, Feingold KR, Elias PM: Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements. Arch Dermatol Res 1995;287:254-258.
62.
Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993;91:1656-1664.
63.
Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 1989;30:323-333.
64.
Proksch E, Elias PM, Feingold KR: Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis: modulation of enzyme content and activation state by barrier requirements. J Clin Invest 1990;85:874-882.
65.
Mao-Qiang M, Elias PM, Feingold KR: Fatty acids are required for epidermal permeability barrier function. J Clin Invest 1993;92:791-798.
66.
Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 1990;86:1738-1745.
67.
Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian epidermal barrier function: inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991;88:1338-1345.
68.
Mao-Qiang M, Feingold KR, Elias PM: Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. J Invest Dermatol 1993;101:185-190.
69.
Lew BL, Cho Y, Kim J, Sim WY, Kim NI: Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-E, and JNK. J Korean Med Sci 2006;21:95-99.
70.
Jacobs RJ: Depleted skin barrier replenishing skin creams composition and method of application. US Patent No US 10/426,493. 2004.
71.
Grubauer G, Feingold KR, Harris RM, Elias PM: Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res 1989;30:89-96.
72.
Kwak S, Brief E, Langlais D, Kitson N, Lafleur M, Thewalt J: Ethanol perturbs lipid organization in models of stratum corneum membranes: an investigation combining differential scanning calorimetry, infrared and 2H NMR spectroscopy. Biochim Biophys Acta 2012;1818:1410-1419.
73.
Imokawa G, Akasaki S, Minematsu Y, Kawai M: Importance of intercellular lipids in water-retention properties of the stratum corneum: induction and recovery study of surfactant dry skin. Arch Dermatol Res 1989;281:45-51.
74.
Jenerowicz D, Silny W, Danczak-Pazdrowska A, Polanska A, Osmola-Mankowska A, Olek-Hrab K: Environmental factors and allergic diseases. Ann Agric Environ Med 2012;19:475-481.
75.
Rawlings AV, Matts PJ: Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. J Invest Dermatol 2005;124:1099-1110.
76.
Rogers J, Harding C, Mayo A, Banks J, Rawlings A: Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 1996;288:765-770.
77.
Both DM, Goodtzova K, Yarosh DB, Brown DA: Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Arch Dermatol Res 2002;293:569-575.
78.
Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G: Analysis of F-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol 1994;74:337-340.
79.
Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD: Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 2001;117:309-317.
80.
Al'Abadie MS, Kent GG, Gawkrodger DJ: The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994;130:199-203.
81.
Kiecolt-Glaser JK, Marucha PT, Malarkey WB, Mercado AM, Glaser R: Slowing of wound healing by psychological stress. Lancet 1995;346:1194-1196.
82.
Gupta MA, Gupta AK: Psychodermatology: an update. J Am Acad Dermatol 1996;34:1030-1046.
83.
Marucha PT, Kiecolt-Glaser JK, Favagehi M: Mucosal wound healing is impaired by examination stress. Psychosom Med 1998;60:362-365.
84.
Vavrova K, Zbytovska J, Palat K, Holas T, Klimentova J, Hrabalek A, Dolezal P: Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. Eur J Pharm Sci 2004;21:581-587.
85.
Farwanah H, Neubert R, Zellmer S, Raith K: Improved procedure for the separation of major stratum corneum lipids by means of automated multiple development thin-layer chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002;780:443-450.
86.
Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y, Kitahara T, Takema Y, Koyano S, Yamazaki S, Hatamochi A: Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 2010;130:2511-2514.
87.
Macheleidt O, Kaiser HW, Sandhoff K: Deficiency of epidermal protein-bound i-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002;119:166-173.
88.
Cho Y, Lew BL, Seong K, Kim NI: An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis. J Korean Med Sci 2004;19:859-863.
89.
Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 1991;32:1151-1158.
90.
Menon GK, Feingold KR, Elias PM: Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992;98:279-289.
91.
Yang L, Mao-Qiang M, Taljebini M, Elias PM, Feingold KR: Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br J Dermatol 1995;133:679-685.
92.
Stover TC, Sharma A, Robertson GP, Kester M: Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005;11:3465-3474.
93.
Chung S, Kong S, Seong K, Cho Y: G-Linolenic acid in borage oil reverses epidermal hyperproliferation in guinea pigs. J Nutr 2002;132:3090-3097.
94.
Barre DE: Potential of evening primrose, borage, black currant, and fungal oils in human health. Ann Nutr Metab 2001;45:47-57.
95.
Bellew S, del Rosso JQ: Overcoming the barrier treatment of ichthyosis: a combination-therapy approach. J Clin Aesthet Dermatol 2010;3:49-53.
96.
Vavrova K, Hrabalek A, Mac-Mary S, Humbert P, Muret P: Ceramide analogue 14S24 selectively recovers perturbed human skin barrier. Br J Dermatol 2007;157:704-712.
97.
Man MM, Feingold KR, Thornfeldt CR, Elias PM: Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 1996;106:1096-1101.
98.
Sahle FF, Metz H, Wohlrab J, Neubert RH: Polyglycerol fatty acid ester surfactant-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterisation, in vitro release and penetration investigation. Eur J Pharm Biopharm 2012;82:139-150.
99.
Sahle FF, Metz H, Wohlrab J, Neubert RH: Lecithin-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterizations, and in vitro release and penetration studies. Pharm Res 2013;30:538-551.
100.
Sahle FF, Wohlrab J, Neubert RH: Controlled penetration of ceramides into and across the stratum corneum using various types of microemulsions and formulation associated toxicity studies. Eur J Pharm Biopharm 2014;86:244-250.
101.
Kato E, Takahashi N: Improvement by sodium dl-E-tocopheryl-6-O-phosphate treatment of moisture-retaining ability in stratum corneum through increased ceramide levels. Bioorg Med Chem 2012;20:3837-3842.
102.
Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S: Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000;143:524-531.
103.
Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, Verdejo P, Feinberg C, Nguyen L, Chandar P: Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res 1996;288:383-390.
104.
Dahl MV, Dahl AC: 12 lactate lotion for the treatment of xerosis: a double-blind clinical evaluation. Arch Dermatol 1983;119:27-30.
105.
Nakahara M, Mishima T, Hayakawa T: Effect of a sake concentrate on the epidermis of aged mice and confirmation of ethyl E-D-glucoside as its active component. Biosci Biotechnol Biochem 2007;71:427-434.
106.
Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993;1182:147-151.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.